You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Investigational Drug Information for ONC201


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for ONC201?

ONC201 is an investigational drug.

There have been 27 clinical trials for ONC201. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2022.

The most common disease conditions in clinical trials are Glioma, Glioblastoma, and Endometrial Neoplasms. The leading clinical trial sponsors are Oncoceutics, Inc., Chimerix, and National Cancer Institute (NCI).

There are fourteen US patents protecting this investigational drug and one hundred and eighty-one international patents.

Recent Clinical Trials for ONC201
TitleSponsorPhase
Testing ONC201 to Prevent Colorectal CancerNational Cancer Institute (NCI)Phase 1
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)ChimerixPhase 3
ONC201 and Atezolizumab in Obesity-Driven Endometrial CancerGenentech, Inc.Phase 1

See all ONC201 clinical trials

Clinical Trial Summary for ONC201

Top disease conditions for ONC201
Top clinical trial sponsors for ONC201

See all ONC201 clinical trials

US Patents for ONC201

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ONC201 ⤷  Try a Trial 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]- pyrimidin-5 (1h)-one, salts thereof and methods of using the same in combination therapy Oncoceutics, Inc. (Philadelphia, PA) ⤷  Try a Trial
ONC201 ⤷  Try a Trial Imipridones for gliomas Oncoceutics, Inc. (Philadelphia, PA) ⤷  Try a Trial
ONC201 ⤷  Try a Trial 7-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy Oncoceutics, Inc. (Philadelphia, PA) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.